| Literature DB >> 29467673 |
Thibault Warlop1,2,3,4,5, Christine Detrembleur2,3, Gaëtan Stoquart1,2,3, Thierry Lejeune1,2,3, Anne Jeanjean4,5.
Abstract
Variability raises considerable interest as a promising and sensitive marker of dysfunction in physiology, in particular in neurosciences. Both internally (e.g., pathology) and/or externally (e.g., environment) generated perturbations and the neuro-mechanical responses to them contribute to the fluctuating dynamics of locomotion. Defective internal gait control in Parkinson's disease (PD), resulting in typical timing gait disorders, is characterized by the breakdown of the temporal organization of stride duration variability. Influence of external cue on gait pattern could be detrimental or advantageous depending on situations (healthy or pathological gait pattern, respectively). As well as being an interesting rehabilitative approach in PD, treadmills are usually implemented in laboratory settings to perform instrumented gait analysis including gait variability assessment. However, possibly acting as an external pacemaker, treadmill could modulate the temporal organization of gait variability of PD patients which could invalidate any gait variability assessment. This study aimed to investigate the immediate influence of treadmill walking (TW) on the temporal organization of stride duration variability in PD and healthy population. Here, we analyzed the gait pattern of 20 PD patients and 15 healthy age-matched subjects walking on overground and on a motorized-treadmill (randomized order) at a self-selected speed. The temporal organization and regularity of time series of walking were assessed on 512 consecutive strides and assessed by the application of non-linear mathematical methods (i.e., the detrended fluctuation analysis and power spectral density; and sample entropy, for the temporal organization and regularity of gait variability, respectively). A more temporally organized and regular gait pattern seems to emerge from TW in PD while no influence was observed on healthy gait pattern. Treadmill could afford the necessary framework to regulate gait rhythmicity in PD. Overall, the results support the hypothesis of a greater dependence to regulatory inputs as an explanatory factor of treadmill influence observed in PD. Also, since treadmill misrepresents the gait as more healthy than it is, the present findings underline that gait analysis using treadmill devices should be cautiously considered in PD and especially for gait variability assessment in gait lab.Entities:
Keywords: Parkinson's disease; fractals; gait analysis; gait variability; locomotion; nonlinear dynamics; rehabilitation; treadmill
Year: 2018 PMID: 29467673 PMCID: PMC5808200 DOI: 10.3389/fphys.2018.00068
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Characteristics of the study populations.
| Age (years) | 65.3 ± 9.6 | 60.1 ± 13.3 | 0.166 |
| Gender | 11 (male) and 9 (female) | 9 (male) and 6 (female) | |
| Height (cm) | 170.3 ± 9.7 | 171.8 ± 5.4 | 0.600 |
| Weight (kg) | 74.0 ± 17.1 | 67.0 ± 10.0 | 0.168 |
| Time since the diagnosis (years) | 4.5 ± 2.7 | – | |
| MMSE score | 29.0 [24–30] | 30.0 [29–30] | 0.014 |
| H&Y scale | 2 [1–3] | – | |
| Most affected/dominant side | 13 (left) and 7 (right) | 2 (left) and 13 (right) | |
| MDS-UPDRS III (/132) | 24.0 [9–66] | – | |
| MDS-UPDRS total (/260) | 49.0 [15–133] | – | |
| BESTest total (%) | 78.0 [49–92] | 88.0 [82–90] | 0.005 |
| ABC Scale (%) | 78.0 [54–100] | 95.0 [76–98] | 0.001 |
Mean (± SD) are expressed for quantitative variables normally distributed while median [range] are expressed for both ordinal and non-normally distributed variables.
Figure 1Stride duration variability. (A) Shows individual changes of Hurst exponent for overground walking (OW) and treadmill walking (TW) in PD and healthy populations. (B) Shows individual changes of α exponent between walking conditions and study populations. (C) Shows individual changes of sample entropy between walking conditions and study populations. (D) Shows individual changes of the coefficient of variation of the stride duration variability between walking conditions and study populations. Boxplots represent the median and the quartiles.
Figure 2Spatiotemporal gait variables. (A) Shows individual changes of gait speed for overground walking (OW) and treadmill walking (TW) in PD and healthy populations. (B) Shows individual changes of gait cadence between walking conditions and study populations. (C) Shows individual changes of step length between walking conditions and study populations. Boxplots represent the median and the quartiles.
Absolute mean values of the stride duration variability and spatiotemporal gait variables for the comparison between the overground walking (OW) and the treadmill walking (TW) sessions in Parkinson's disease and healthy subjects.
| H exponent | 0.66 (±0.17) | 0.89 (±0.14) | −4.925 | 0.78 (±0.07) | 0.82 (±0.12) | −1.162 | 0.264 | |
| α exponent | 0.46 (±0.16) | 0.81 (±0.27) | −4.595 | 0.54 (±0.14) | 0.56 (±0.20) | −0.376 | 0.713 | |
| Sample Entropy | 1.89 (±0.24) | 1.71 (±0.27) | 2.688 | 1.94 (±0.19) | 1.93 (±0.13) | 0.302 | 0.767 | |
| CV (%) | 2.88 (±1.34) | 4.53 (±3.00) | −2.932 | 1.91 (±0.54) | 2.18 (±1.25) | −0.912 | 0.377 | |
| Gait speed (m/s) | 1.15 (±0.16) | 0.74 (±0.27) | 9.929 | 1.34 (±0.16) | 1.23 (±0.16) | 2.060 | 0.059 | |
| Gait cadence (#steps/min) | 111.85 (±8.12) | 102.78 (±6.46) | 3.934 | 113.83 (±10.13) | 109.80 (±8.83) | 2.411 | ||
| Step length (m) | 0.61 (±0.09) | 0.41 (±0.14) | 9.147 | 0.70 (±0.07) | 0.67 (±0.07) | 1.438 | 0.173 | |
Absolute value is expressed as mean (± SD). Bold data indicates if the comparison between UW and NW (paired t-test) was significant (p < 0.05).
Figure 3Effect size and confidence intervals for the differences between overground and treadmill walking. Black circles (PD patients) and white squares (Healthy controls) are the standardized effect size (Hedge's g). Horizontal lines are the 95% confidence intervals. Vertical dotted lines, arbitrarily fixed at 0.5 and−0.5, correspond to a medium effect as defined by Cohen.
Results of a Two-Way Repeated Measures ANOVA with walking condition (OW and TW) and pathological condition (Healthy controls and PD) as main factors on stride duration variability and spatiotemporal gait variables.
| H exponent | 0.66 (±0.17) | 0.89 (±0.14) | 0.78 (±0.07) | 0.82 (±0.12) | 26.383 | 0.999 | 0.325 | 12.193 | 0.088 | |
| α exponent | 0.46 (±0.16) | 0.81 (±0.27) | 0.54 (±0.14) | 0.56 (±0.20) | 13.772 | 3.727 | 0.062 | 10.921 | ||
| Sample Entropy | 1.89 (±0.24) | 1.71 (±0.27) | 1.94 (±0.19) | 1.93 (±0.13) | 4.572 | 5.555 | 3.088 | |||
| CV (%) | 2.88 (±1.34) | 4.53 (±3.00) | 1.91 (±0.54) | 2.18 (±1.25) | 6.934 | 12.306 | 3.698 | 0.063 | ||
| Gait speed (m/s) | 1.15 (±0.16) | 0.74 (±0.27) | 1.34 (±0.16) | 1.23 (±0.16) | 63.757 | 32.637 | 23.055 | |||
| Gait cadence (#steps/min) | 111.85 (±8.12) | 102.78 (±6.46) | 113.83 (±10.13) | 109.80 (±8.83) | 18.634 | 3.067 | 0.089 | 3.160 | 0.085 | |
| Step length (m) | 0.61 (±0.09) | 0.41 (±0.14) | 0.70 (±0.07) | 0.67 (±0.07) | 49.672 | 41.188 | 29.263 | |||
Bold data indicates statistically significant differences (p < 0.05).
Mean values of the normalized stride duration variability and spatiotemporal gait variables (Z score) for the comparison between the overground walking (OW) and the treadmill walking (TW) sessions in Parkinson's disease.
| H exponent | −1.71 (±2.48) | 0.46 (±1.02) | −4.934 | |
| α exponent | −0.58 (±1.13) | 1.33 (±1.35) | −4.319 | |
| Sample Entropy | −0.38 (±1.26) | −1.60 (±1.90) | 2.911 | |
| CV (%) | 1.81 (±2.49) | 1.88 (±2.39) | −0.143 | 0.888 |
| Gait speed (m/s) | −1.72 (±1.13) | −4.71 (±1.95) | 9.929 | |
| Gait cadence (#steps/min) | −0.19 (±1.42) | 1.15 (±1.84) | −5.314 | |
| Step length (m) | −0.53 (±0.52) | −1.05 (±0.42) | 5.739 | |
Z-score is expressed as mean (± SD). Bold data indicates if the comparison is significantly different (p < 0.05).
Correlations study between the changes of both stride duration variability and gait parameters with clinical parameters in Parkinson's disease.
| Age | −0.28 | −0.08 | −0.11 | 0.18 | −0.05 | −0.06 | −0.18 |
| Disease duration | 0.38 | 0.43 | 0.13 | 0.04 | −0.29 | 0.16 | −0.39 |
| H&Y scale | −0.18 | 0.09 | −0.35 | 0.20 | −0.39 | ||
| MDS-UPDRS III | −0.27 | 0.09 | −0.32 | 0.22 | − | ||
| BESTest | − | − | 0.20 | −0.19 | −0.11 | ||
| ABC-Scale | −0.22 | − | −0.15 | −0.20 | −0.13 | ||
| Gait speed change | 0.14 | −0.35 | −0.05 | − | 0.42 | ||
The change expresses the difference between the two walking conditions (OW and TW).
p ≤ 0.001;
p ≤ 0.01;
p ≤ 0.05. Bold data indicates statistically significant correlations (p < 0.05).